Immunocore Holdings plc ADR [IMCR] stock is trading at $27.87, up 2.05%. An important factor to consider is whether the stock is rising or falling in short-term value. The IMCR shares have gain 6.70% over the last week, with a monthly amount drifted -1.78%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Immunocore Holdings plc ADR [NASDAQ: IMCR] stock has seen the most recent analyst activity on December 13, 2024, when Morgan Stanley downgraded its rating to a Equal-Weight and also revised its price target to $35 from $74. Previously, Mizuho downgraded its rating to Neutral on November 11, 2024, and dropped its price target to $38. On October 24, 2024, UBS initiated with a Sell rating and assigned a price target of $24 on the stock. Guggenheim downgraded its rating to a Neutral. Leerink Partners initiated its recommendation with a Outperform and recommended $74 as its price target on April 29, 2024. In a note dated November 02, 2023, Cantor Fitzgerald initiated an Overweight rating.
Immunocore Holdings plc ADR [IMCR] stock has fluctuated between $23.15 and $62.74 over the past year. Currently, Wall Street analysts expect the stock to reach $29.5 within the next 12 months. Immunocore Holdings plc ADR [NASDAQ: IMCR] shares were valued at $27.87 at the most recent close of the market. An investor can expect a potential return of 5.85% based on the average IMCR price forecast.
Analyzing the IMCR fundamentals
Immunocore Holdings plc ADR [NASDAQ:IMCR] reported sales of 310.29M for the trailing twelve months, which represents a growth of 17.66%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.14 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.77 points at the first support level, and at 25.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.58, and for the 2nd resistance point, it is at 29.28.
Ratios To Look Out For
For context, Immunocore Holdings plc ADR’s Current Ratio is 4.38. On the other hand, the Quick Ratio is 4.36, and the Cash Ratio is 2.15. Considering the valuation of this stock, the price to sales ratio is 4.50, the price to book ratio is 3.89.
Transactions by insiders
Recent insider trading involved BAKER BROS. ADVISORS LP, Director, that happened on Mar 17 ’25 when 0.81 million shares were purchased. affiliate, Brian Di Donato completed a deal on Mar 17 ’25 to buy 100000.0 shares. Meanwhile, affiliate Brian Di Donato bought 56250.0 shares on Mar 14 ’25.
